Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to make IUD insertion less painful

NCT ID NCT07546370

Symptom relief Sponsor: Monakshi Sawhney Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two pain management methods for IUD insertion: a numbing cream plus pain pills versus a lidocaine injection plus pain pills. About 66 people with a uterus who want an IUD for birth control will take part. The goal is to see which approach works better and is safer for reducing pain during the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 66 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Nulliparous, parous female or non operative trans male * Participants want to have an IUD for contraception * Able to provide consent * Participants are between the ages of 18-45 years old * Individuals must meet the medical eligibility criteria for an IUD Exclusion Criteria: * pregnant or if pregnancy can not be ruled out the day of insertion * have abnormal uterine bleeding that has not been investigated * Lupus * liver disease * progesterone sensitive tumors * molar pregnancy * gynecological malignancy * breast cancer * clotting disorders * uterine anomalies * septic abortion within last three months * allergy to progesterone or copper * pelvic inflammatory disease * acute malignancies affecting blood * bacterial endocarditis * methemoglobinemia * allergy to prilocaine-lidocaine cream * actively breastfeeding * Participants taking beta-blockers and/ or antiarrhythmic drugs * Individuals who have taken opioids or benzodiazepines within 24 hours prior to the procedure * Participants who are currently using an IUD

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pain during intrauterine device insertion are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pain during intrauterine device insertion

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Woodlawn Medical Clinic

    Dartmouth, Nova Scotia, B2W 2S7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.